Brief: Biofrontera AG Resolves Capital Increase From Authorized Capital
04/04/2024 18:52
Biofrontera AG B8FGn.DE :
* RESOLVES CAPITAL INCREASE FROM AUTHORIZED CAPITAL
* : BASED ON RESOLUTIONS ADOPTED AT TODAY'S SHAREHOLDERS'
MEETING
TO REDUCE COMPANY'S SHARE CAPITAL TO EUR 3.04 MILLION
* : SUBSCRIPTION PRICE IS TO BE EUR 1.10 PER SHARE.
* : FUNDS FROM CAPITAL INCREASE WILL BE USED TO FINANCE
OPERATING
ACTIVITIES
Source text for Eikon: ID:nPexnm1NQa
Further company coverage: B8FGn.DE
Recent news on Biofrontera AG
See all newsBrief: Biofrontera Says Co And Units Have Entered Into An Agreement With Biofrontera Inc About How To Settle Payment Obligations By Biofrontera Inc
Brief: Biofrontera AG Says Legal Dispute On Import In USA Will Result In Revised Outlook
Brief: Biofrontera AG Resolves Capital Increase From Authorized Capital
Brief: Biofrontera AG Says Plans Capital Reduction And Considers Subsequent Capital Increase From Authorized Capital
Brief: Biofrontera AG Says FY 2022 Total Revenue Amounted To EUR 25.7 Million